Sanofi-Aventis agrees to pay almost $12 million to resolve allegations that it violated the False Claims Act by paying kickbacks to Medicare patients ...
FDA accepts for review a Pfizer and Eli Lilly BLA for tanezumab 2.5 mg administered subcutaneously for patients with chronic pain due to moderate-to-s...
FDA approves a Sanofi BLA for Sarclisa (isatuximab-irfc) in combination with pomalidomide and dexamethasone for treating adults with relapsed refracto...
Sandoz agrees to pay a $195 million criminal penalty under a deferred prosecution agreement in an ongoing generic drug price-fixing investigation.
FDA Review posts the Federal Register notices for the week ending 2/28/2020.
FDA says an unidentified drug manufacturer has alerted the agency about a drug shortage related to a manufacturing site affected by the coronavirus.
The Association for Accessible Medications steps up pressure on Congress to reject legislation to change FDAs 180-day marketing exclusivity awards for...